top of page
.
Concord Biotech Ltd.
Last Updated
10-Jun-26
CONCORDBIO
INE338H01029
Healthcare
Bullish
Mid Cap
Close Price
10-Jun-26
₹1,330.70
Latest Announcement
Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval for Tofacitinib Tablets, 5 mg and 10 mg
4.60%
PE
51.92
Open
₹1,284.00
Day High
₹1,349.90
Day Low
₹1,282.60
Prev. Close
₹1,330.70
52-Week Range
52W Low
₹987.00
Annual Bottom
Current
₹1,330.70
52W High
₹2,150.40
Annual Peak
% Below 52W High
38.12%
% Below 52W Low
34.82%
Key Metrics
Market Cap
₹139,212,782,662.80
Mid Cap
% Change
4.60%
RSI
Neutral
Volatility
Volatile
Price & Trading Activity
Session Prices
Open
₹1,284.00
High
₹1,349.90
Low
₹1,282.60
Close
₹1,330.70
Prev. Close
₹1,272.20
% Change
4.60%
Gap %
0.93%
Daily Range %
5.25%
Candle
Bullish
Trading Activity
Traded Value
₹1,616,844,316.30
Traded Qty
1,214,704
No. of Trades
73,415
Avg Trade Value
₹15,558.78
Avg Trade Qty
13.42
RSI
63.35
RSI Signal
Neutral
Volatility %
5.41%
Delivery
Data N/A
Company Information
Identifiers
Company Name
Concord Biotech Ltd.
Symbol
CONCORDBIO
ISIN
INE338H01029
Series
EQ
Industry
Healthcare
Last Updated
10-Jun-26
Market Data
Market Cap
₹139,212,782,662.80
Cap Category
Mid Cap
Issue Size
104,616,204
52W High
₹2,150.40
52W Low
₹987.00
Smart Label
Volatile
Research Note
Concord Biotech Ltd. (CONCORDBIO) in Healthcare has a market cap of ₹13,921.28 Cr. On June 10th, it closed at ₹1,330.70 (a 4.60% gain). It is currently outperforming the Nifty Total Market with a 5.41% volatility spread. Note: Volatile.
Financial Calculators & Tools
bottom of page